Cargando…
Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808026/ https://www.ncbi.nlm.nih.gov/pubmed/29149106 http://dx.doi.org/10.1038/bjc.2017.406 |
| _version_ | 1783299383610048512 |
|---|---|
| author | Triggiani, Luca Mazzola, Rosario Magrini, Stefano Maria Alongi, Filippo Buglione, Michela |
| author_facet | Triggiani, Luca Mazzola, Rosario Magrini, Stefano Maria Alongi, Filippo Buglione, Michela |
| author_sort | Triggiani, Luca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5808026 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58080262019-02-06 Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ Triggiani, Luca Mazzola, Rosario Magrini, Stefano Maria Alongi, Filippo Buglione, Michela Br J Cancer Letter to the Editor Nature Publishing Group 2018-02-06 2017-11-16 /pmc/articles/PMC5808026/ /pubmed/29149106 http://dx.doi.org/10.1038/bjc.2017.406 Text en Copyright © 2018 http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Letter to the Editor Triggiani, Luca Mazzola, Rosario Magrini, Stefano Maria Alongi, Filippo Buglione, Michela Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| title | Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| title_full | Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| title_fullStr | Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| title_full_unstemmed | Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| title_short | Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| title_sort | reply to ‘comment on ‘efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808026/ https://www.ncbi.nlm.nih.gov/pubmed/29149106 http://dx.doi.org/10.1038/bjc.2017.406 |
| work_keys_str_mv | AT triggianiluca replytocommentonefficacyofstereotacticbodyradiotherapyinoligorecurrentandinoligoprogressiveprostatecancernewevidencefromamulticentricstudy AT mazzolarosario replytocommentonefficacyofstereotacticbodyradiotherapyinoligorecurrentandinoligoprogressiveprostatecancernewevidencefromamulticentricstudy AT magrinistefanomaria replytocommentonefficacyofstereotacticbodyradiotherapyinoligorecurrentandinoligoprogressiveprostatecancernewevidencefromamulticentricstudy AT alongifilippo replytocommentonefficacyofstereotacticbodyradiotherapyinoligorecurrentandinoligoprogressiveprostatecancernewevidencefromamulticentricstudy AT buglionemichela replytocommentonefficacyofstereotacticbodyradiotherapyinoligorecurrentandinoligoprogressiveprostatecancernewevidencefromamulticentricstudy |